Weighted Average Number of Shares Outstanding, Basic of Terns Pharmaceuticals, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Terns Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q3 2025.
  • Terns Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 91.7M shares, a 17.8% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 79.5M shares, a 11.6% increase from 2023.
  • Terns Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 71.3M shares, a 97.8% increase from 2022.
  • Terns Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 36M shares, a 58.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Terns Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 91.7M +13.9M +17.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 91.6M +17.1M +23% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 91.5M +17.1M +23% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 79.5M +8.25M +11.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 77.8M +6.29M +8.79% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 74.5M +3.1M +4.34% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 74.4M +4.62M +6.62% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 71.3M +35.2M +97.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 71.5M +33M +85.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 71.4M +46.1M +182% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 69.8M +44.5M +176% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 36M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 38.5M +13.4M +53.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 25.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 25.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 25.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09

Terns Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 79.5M +8.25M +11.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 71.3M +35.2M +97.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 36M +13.3M +58.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 22.7M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.